Panasonic and Pika up the pace
Pika Energy has increased its home battery capacity to 17.1 kWh – about half an average home’s daily usage. The units are powered by Panasonic lithium-ion cells.
The path to 1.5¢/kWh solar power, and lower
GTM Research projects 24¢/w solar panels and utility scale fixed-tilt systems at $0.70/W by 2022, which opens up new possibilities for ultra-cheap power from solar.
Hurricane Maria moves Solartech Universal’s expansion to South Florida
Solartech Universal plans to expand its current 80 MW/year capacity by 180 MW/year. The company is seeking a facility in South Florida.
Tesla and Panasonic to hire 80 workers at Buffalo gigafactory
The Tesla/Panasonic gigafactory is taking on more workers, as a sign of health. However many details remain unclear.
Republicans request utility-scale solar panel tariff exemption
A group of eight Republican senators has sent a letter to the U.S. Trade Representative and other federal agencies calling for utility-scale solar panels to be exempt from the Section 201 tariffs.
California residential solar power headed toward $1/W and 2.5¢/kWh
ASU energy security researcher Dr. Wesley Herche and pv magazine author John Weaver describe the new math involved with requiring solar power to be installed at the time of construction for newly built homes.
Panasonic, Tesla reveal plan to produce lithium batteries in China
Tesla’s batteries may soon be Made in China. The announcement was made by Panasonic CEO Kazuhiro Tsuga during a conference accompanying the company’s 2018 fiscal-year results.
SunPower to exit utility-scale solar development
The company is pivoting to DG solar and expanding its manufacturing as it continues to struggle with profitability.
Enphase sees CFO leave, presents stable numbers for Q1 2018
The microinverter maker is reporting only modest losses in its Q1 results, a significant improvement from a year ago.
Wanxiang gets permission to auction off more Suniva assets
The ruling follows on bankruptcy court approval of SQN’s request to sell off its share of Suniva’s tools and assets, in what may be the bitter end of Suniva as a cell maker.
